Product
Supplier
Encyclopedia
Inquiry
Retatrutide10mg. buy - large image1
Retatrutide10mg. buy - image1
Retatrutide10mg. buy - image2
Retatrutide10mg. buy - image3
Retatrutide10mg. buy - image4
Retatrutide10mg. buy - image5
Retatrutide10mg. buy - image6

Retatrutide10mg.

TDS 7186 Inquiries

Unit Price:

$35-38/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shenzhen

Brand:

HL

Packaging:

10MG

Sample Available:

Yes

Price valid (until):

2026-10-29

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

polypeptide,Retatrutide,Tirzepatide,Semaglutide,Glow,Benzyl Alcohol

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Huilong is a high-end brand company focusing on the biomedical industry and integrating R&D, production and sales. It has an independent R&D center, advanced laboratory equipment and a professional R&D team, a GMP standard production workshop, a complete set of internationally advanced assembly line equipment, a preparation workshop with a cleanliness level of 100,000, as well as sophisticated testing instruments and scientific testing methods, providing solid technical support for the production of high-quality products. Through long-term R&D, production, and sales practices, it has formed its own unique product line, providing users with products of reliable quality at highly affordable prices. We strictly control quality, ensure the stability of product quality in all aspects, and win the trust of customers with high quality and high-level development.

    Our team of experienced professionals is committed to delivering innovative solutions and exceptional customer service. We work closely with our clients to understand their unique needs and develop customized products to meet their specific requirements. With a state-of-the-art manufacturing facility and strict quality control measures, we ensure that our products meet the highest standards of safety and purity.

    We have been keeping providing new products to the markets of Europe,America,Australia,Japan and South-east Asia,etc. We always insist on our company's principle or quality & credit are first"and after several years of development,we have enjoyed good reputation in the fitness industry.

    We try our best to provide first-class goods,competitive price and supreme service to meet every client's requirements. We look forward to establish a long-term business relationship with you on the basis of equality and mutual benefits.


    Items Specifications purity Packaging method
    Semaglutide 5mg 10mg 15mg 20mg 30mg ≥99.5% 10 vials  /  boxs

    Retatrutide

    5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg  ≥99.5% 10 vials  /  boxs
    Tirzepatide 5mg 10mg 15mg 20mg 30mg 40mg 50mg 60mg 100mg 120mg  ≥99.5% 10 vials  /  boxs
    AHK-CU 50mg  100mg ≥99.5% 10 vials  /  boxs
    GLOW70 70mg ≥99.5% 10 vials  /  boxs
    MOTS-C 10mg   20mg  30mg  40mg  ≥99.5% 10 vials  /  boxs
    NSD+ 100mg   500mg  1000mg ≥99.5% 10 vials  /  boxs
    BAC  Water 3ml        10ml ≥99.5% 10 vials  /  boxs

    Research and Development Center



    Shop Retatrutide10mg.-Detailed Image 1


    COA Certificate

    Shop Retatrutide10mg.-Detailed Image 2 Shop Retatrutide10mg.-Detailed Image 3
    Shop Retatrutide10mg.-Detailed Image 4 Shop Retatrutide10mg.-Detailed Image 5

    Customer feedback and positive reviews

    Shop Retatrutide10mg.-Detailed Image 6

    Safe and fast delivery


    Shop Retatrutide10mg.-Detailed Image 7



    Semaglutide,Retatrutide,Tirzepatide,BBG70,Glow, GHK-CU, DAC,CBL60 Cerebrolysin,Glutathione,IGF-1LR3,KLOW80,KPV10,LC216,Lemon Bottle,L-carnitine 600mg,Melanotan,MOTS-c ,NJ100,NAD+,Snap-8,Benzyl Alcohol 0.9%,BAC Water, water 0.6%,

    Weight loss and blood sugar reduction, weight loss, multiple receptor agonists, treatment of obesity and metabolic diseases, growth hormone, neuronal stimulation, acceleration of postoperative intestinal obstruction, stimulation of gastric contraction, wound healing, soft tissue repair, and anti-inflammatory effects, reducing body fat, especially abdominal fat, infertility, in vitro fertilization, infertility, sexual dysfunction, tanning, sexual dysfunction, promotion of deep sleep, prostate cancer, endometriosis, precocious puberty and other hormone related diseases, relieving anxiety, oxytocin, childbirth, lactation and emotional connection, anti-aging and anti-aging, enhancing muscle mass, improving endurance, promoting fat burning, improving insulin sensitivity, destroying fat structure, thereby achieving weight loss effects, neurodegenerative diseases, stroke recovery, etc. Cognitive impairment, Neuroprotection, cardiac protection, anti-aging, accelerating recovery after training, promoting muscle growth, increasing athletic performance, acetate growth hormone, muscle repair, anti-aging, improving metabolism and enhancing immune function, acting as a stimulant during exercise, increasing muscle and skeletal tissue growth, muscle repair, anti-aging, athletic performance and treatment of muscle atrophy, muscle growth, tissue repair and fat metabolism (in freeze-dried powder form), temorelin HIV AIDS fat metabolism disorder, collagen synthesis, increasing cell regeneration, slowing down the aging process and accelerating wound healing, infertility, hypogonadism, male infertility, female ovulation disorder, analgesic effect, hyaluronic acid, moisturizing, repairing, promoting cell growth, Alzheimer's disease, post stroke rehabilitation, brain damage, long-distance running, cycling, swimming and other endurance projects,


    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.
    Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.

    Certificates
    • Retatrutide10mg. Certificates 1 TDS

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    0

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    polypeptide,Retatrutide,Tirzepatide,Semaglutide,Glow,Benzyl Alcohol

    Location:

    Room 1403, 3/4, Qinglin Building, South of Dongjiang Road, Hexi District, Tianjin

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

    Company Certificates
    • Hulong Biotechnology Co., LtdCOA COA
    • Hulong Biotechnology Co., LtdCOA COA


      Company Profile  


  • Inquiry History
    7186 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Palestine

    Factory 99% Purity Retatrutide Peptide CAS 2381089-83-2 Door-To-Door Service

    10 MG Mar 16, 2026
    Post an enquiry for this product

More from this Seller

pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.